XML 116 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue - Major Products (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Revenue from External Customer [Line Items]                      
Revenue, net $ 54,777 $ 51,570 $ 59,007 $ 54,827 $ 59,368 $ 56,077 $ 61,242 $ 56,228 $ 220,181 $ 232,915 $ 225,958
Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 100.00% 100.00% 100.00%
Protandim® product line                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 150,272 $ 156,335 $ 144,100
Protandim® product line | Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 68.20% 67.10% 63.80%
TrueScience® product line                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 22,617 $ 23,739 $ 24,853
TrueScience® product line | Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 10.30% 10.20% 11.00%
Other                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 47,292 $ 52,841 $ 57,005
Other | Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 21.50% 22.70% 25.20%